Kao Corporation Earnings Call Transcripts
Fiscal Year 2025
-
Fiscal 2025 delivered strong sales and profit growth, with improved margins and ROIC, driven by robust performance in Japan and recovery in key overseas segments. Fiscal 2026 guidance projects continued growth, supported by new product launches, digital transformation, and strategic capital allocation.
-
Earnings for the nine months ended September 2025 showed strong sales and profit growth, with operating margin and ROIC both at 9.3%. Cosmetics and GC businesses led recovery, while cost controls and price increases offset raw material pressures.
-
Solid first-half results led to upward revisions in full-year forecasts for sales and operating income, driven by strong performance in Japan, successful product launches, and ongoing structural reforms. Share repurchase and improved capital efficiency further support growth ambitions.
-
First quarter saw strong sales and margin growth, with operating income up 38.7% year-over-year. Cosmetics and UV Care segments drove performance, while tariff and raw material risks are being actively managed. Full-year guidance is maintained.
Fiscal Year 2024
-
Strong profit recovery in 2024 was driven by higher value-added products, cost reductions, and improved brand loyalty, with all key metrics exceeding expectations. 2025 guidance anticipates continued growth, especially in cosmetics and global expansion, despite rising raw material costs and ongoing challenges in China.
-
Structural reforms and high-value-added product strategies drove strong profit and margin growth, with ROIC up 4.9 points and operating income up 42.8% year-over-year. China cosmetics remains a drag, but gains from business transfers and global expansion support positive outlook.
-
First-half profit surged 68% year-over-year, driven by structural reforms and high-value-added products, with strong gains in core brands and chemicals. Full-year operating income forecast was raised to JPY 140 billion, but China cosmetics remain a drag.